Covidien

From Food & Medicine Encyclopedia

Covidien[edit]

Covidien plc was a global healthcare leader primarily focused on medical devices and supplies. The company had its roots in a diverse array of historic businesses and brands with a presence in over 150 countries.

Covidien Logo

Overview[edit]

Covidien, with its diversified product line, was recognized for its commitment to innovation in patient care. The company was actively involved in producing surgical solutions, vascular therapies, respiratory and patient care.

History[edit]

  • 1903: The company's origins trace back to the founding of the Kendall Company, a manufacturer of cotton and gauze health care products.
  • 1990s: The Kendall Company becomes part of Tyco Healthcare, a division of Tyco International.
  • 2007: Tyco Healthcare was spun off and became an independent company, adopting the name Covidien.
  • 2015: Medtronic, a global leader in medical technology, services, and solutions, acquired Covidien in a deal valued at nearly $50 billion.

Key Divisions and Products[edit]

  • Surgical Solutions: Covidien was a prominent player in the surgical market, providing advanced medical devices for minimally invasive procedures.
  • Vascular Therapies: The company produced devices and solutions for vascular diseases, including venous therapies and arterial embolization.
  • Respiratory and Patient Care: This division focused on solutions for airway management, ventilators, and patient monitoring.

Research and Development[edit]

Covidien invested heavily in R&D to ensure continuous innovation in its product lines. They worked closely with the medical community to understand needs and challenges, leading to the development of cutting-edge solutions.

Corporate Responsibility[edit]

Covidien had an active CSR wing dedicated to social and environmental responsibilities. Their initiatives ranged from reducing their carbon footprint to community outreach programs.

Acquisitions and Mergers[edit]

Covidien strategically acquired several companies during its tenure, expanding its product range and geographical presence. The most significant was its merger with Medtronic in 2015.

Facilities[edit]

With its vast global presence, Covidien had manufacturing, R&D, and commercial operations spread across multiple continents.

See Also[edit]

References[edit]

  • [1] "The Legacy of Covidien". MedTech Dive Magazine.
  • [2] "Medtronic-Covidien Merger: A New Beginning". The Wall Street Journal.
  • [3] "Covidien's Corporate Responsibility Report". Covidien Official Report.


Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.